Cancer cells that have broken away from a primary tumor can lurk in the body for years in a dormant state, evading immune ...

Large cell carcinoma is aggressive, requiring early detection through imaging and biopsy for optimal treatment outcomes.

When lung cancer treatment stops working, what happens next? New research reveals the answer may depend on how the cancer grows.

Microsoft and Bristol Myers Squibb have signed a new pact aimed at identifying lung cancer cases more quickly. | Microsoft ...

A recent study has analyzed the relationship between different air pollutants and the main subtypes of lung cancer.

Despite a significant 48.8% objective response rate and breakthrough therapy status, this regulatory shift reverses years of ...

The cancer gene MYC camouflages tumors by suppressing alarm signals that normally activate the immune system. This finding from a new study offers a promising way to improve existing cancer therapies ...

Researchers explored why only 40 percent of patients responded to Amgen's Imdelltra using TellBio's liquid biopsy test and ...

GMCL1-dependent degradation of 53BP1 suppresses mitotic surveillance, tuning p53 activation thresholds that govern cell fate decisions and cellular responses after mitosis.